94 related articles for article (PubMed ID: 3013561)
1. Epirubicin pharmacokinetics after intrahepatic arterial and intraperitoneal administration.
Strocchi E; Camaggi CM; Rossi AP; Angelelli B; Comparsi R; Franchini A; Del Prete P; Cola B; Pannuti F
Drugs Exp Clin Res; 1985; 11(4):295-301. PubMed ID: 3013561
[TBL] [Abstract][Full Text] [Related]
2. Intrahepatic arterial administration of 4'epidoxorubicin (epirubicin) in advanced cancer patients. A pharmacokinetic study.
Pannuti F; Camaggi CM; Strocchi E; Comparsi R; Rossi AP; Angelelli B; Franchini A
Eur J Cancer Clin Oncol; 1986 Nov; 22(11):1309-14. PubMed ID: 3470178
[TBL] [Abstract][Full Text] [Related]
3. Epirubicin plasma and blood pharmacokinetics after single i.v. bolus in advanced cancer patients.
Camaggi CM; Strocchi E; Martoni A; Angelelli B; Comparsi R; Pannuti F
Drugs Exp Clin Res; 1985; 11(4):285-94. PubMed ID: 3869807
[TBL] [Abstract][Full Text] [Related]
4. Lattice intrahepatic doxorubicin with and without in-flow occlusion: a pharmacokinetic study of direct liver injection.
Averbach A; Stuart OA; Chang D; Sugarbaker PH
Eur J Surg Oncol; 2000 Feb; 26(1):73-9. PubMed ID: 10718184
[TBL] [Abstract][Full Text] [Related]
5. [Intra-arterial administration of epirubicin in the treatment of non-resectable hepatocellular carcinoma. Epirubicin Study Group for Hepatocellular Carcinoma].
Nagasue N; Yukaya H; Okamura J; Kuroda C; Kubo Y; Hirai K; Tanikawa K; Okita K; Ando K; Tamura K
Gan To Kagaku Ryoho; 1986 Sep; 13(9):2786-92. PubMed ID: 3019251
[TBL] [Abstract][Full Text] [Related]
6. Intrahepatic epidoxorubicin in metastatic and primary liver tumours: a phase II study.
Nobile MT; Vidili MG; Sertoli MR; Venturini M; Simoni G; Civalleri D; Bertoglio S; Percivale P; Torelli P; Spagliardi E
Anticancer Res; 1991; 11(2):861-4. PubMed ID: 2064343
[TBL] [Abstract][Full Text] [Related]
7. [Study of intra-arterial infusion chemotherapy for hepatocellular carcinoma using an implantable reservoir].
Maruo H; Kosaka A
Gan To Kagaku Ryoho; 1993 Aug; 20(11):1473-6. PubMed ID: 8396899
[TBL] [Abstract][Full Text] [Related]
8. [Results of clinical study with epirubicin hydrochloride injectable solution in hepatoma].
Monden M; Nakamura H; Yayoi E; Monden T; Ohi H; Arisawa J; Masuzawa M; Shimizu T; Tomono N; Seki K; Nakao N; Todo A; Inoue Y; Sakon M; Ohsaki Y; Hosoki T
Gan To Kagaku Ryoho; 1998 Sep; 25(11):1713-9. PubMed ID: 9757197
[TBL] [Abstract][Full Text] [Related]
9. [Hepatic arterial infusion chemotherapy using totally implantable port system].
Takayasu Y; Yamamoto S; Ikeda J
Gan To Kagaku Ryoho; 2000 Sep; 27(10):1516-20. PubMed ID: 11015995
[TBL] [Abstract][Full Text] [Related]
10. Hepatic arterial infusion chemotherapy with use of an implanted port system in patients with advanced hepatocellular carcinoma: prognostic factors.
Hamada A; Yamakado K; Nakatsuka A; Takaki H; Akeboshi M; Takeda K
J Vasc Interv Radiol; 2004 Aug; 15(8):835-41. PubMed ID: 15297587
[TBL] [Abstract][Full Text] [Related]
11. [Three cases of multiple colorectal liver metastases responding to hepatic arterial infusion chemotherapy undergoing liver resection].
Kobayashi K; Ueki K; Ishizuka D; Wakakuwa R
Gan To Kagaku Ryoho; 2005 Mar; 32(3):389-91. PubMed ID: 15791824
[TBL] [Abstract][Full Text] [Related]
12. Comparative pharmacokinetics and metabolism of doxorubicin and epirubicin in patients with metastatic breast cancer.
Robert J; Vrignaud P; Nguyen-Ngoc T; Iliadis A; Mauriac L; Hurteloup P
Cancer Treat Rep; 1985 Jun; 69(6):633-40. PubMed ID: 3893693
[TBL] [Abstract][Full Text] [Related]
13. Cardio-pulmonary elimination of 5-fluorouracil after bolus injection in the hepatic artery.
Andersson M; Billström A; Domellöf L; Gustavsson B
Eur J Surg Oncol; 1987 Feb; 13(1):35-9. PubMed ID: 3028867
[TBL] [Abstract][Full Text] [Related]
14. [Effect on hepatic function of hepatic artery infusion chemotherapy using epirubicin and mitoxantrone for advanced hepatocellular carcinoma].
Murata T; Nasu R; Kimura H; Uokawa K; Nagata K; Akagi K; Tanaka Y
Gan To Kagaku Ryoho; 1998 Sep; 25(11):1707-11. PubMed ID: 9757196
[TBL] [Abstract][Full Text] [Related]
15. Combined therapy with external beam irradiation and hepatic arterial epirubicin infusion through an implanted port for advanced hepatocellular carcinoma.
Takizawa K; Honda M; Obuchi M; Hasebe S; Matsuoka S; Yamada M; Kuniyasu Y
Semin Oncol; 1997 Apr; 24(2 Suppl 6):S6-116-S6-121. PubMed ID: 9151926
[TBL] [Abstract][Full Text] [Related]
16. [Repeated arterial infusion of zinostatin stimalamer using port for advanced hepatocellular carcinoma].
Yoshikawa M; Ebara M; Fukuda H; Sugiura N; Saisho H
Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():30-3. PubMed ID: 9512684
[TBL] [Abstract][Full Text] [Related]
17. A phase I/II trial of chemoembolization for hepatocellular carcinoma using a novel intra-arterial drug-eluting bead.
Poon RT; Tso WK; Pang RW; Ng KK; Woo R; Tai KS; Fan ST
Clin Gastroenterol Hepatol; 2007 Sep; 5(9):1100-8. PubMed ID: 17627902
[TBL] [Abstract][Full Text] [Related]
18. Single catheter technique of hepatic venous isolation and extracorporeal charcoal hemoperfusion for malignant liver tumors.
Ku Y; Fukumoto T; Tominaga M; Iwasaki T; Maeda I; Kusunoki N; Obara H; Sako M; Suzuki Y; Kuroda Y; Saitoh Y
Am J Surg; 1997 Feb; 173(2):103-9. PubMed ID: 9074373
[TBL] [Abstract][Full Text] [Related]
19. Comparative pharmacokinetics of doxorubicin and epirubicin in patients with gastrointestinal cancer.
Peterson C; Gunvén P; Theve NO
Cancer Treat Rep; 1986 Aug; 70(8):947-52. PubMed ID: 3460699
[TBL] [Abstract][Full Text] [Related]
20. [Combined intra-arterial locoregional and systemic treatment of nonresectable hepatic metastases of colorectal carcinoma].
Cantore M; Aitini E; Rabbi C; Cavazzini G; Bertani M; Pulica C; Campo S; Pari F; Mambrini A; Bezzi A; Zamagni D; Amadori M; Smerieri F
G Chir; 1997 Apr; 18(4):235-9. PubMed ID: 9303640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
